| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Merus N.V. | Director | Share Option (right to buy) | 8.84K | $120K | $13.52 | May 7, 2024 | Direct |
| Aclaris Therapeutics, Inc. | Director | Common Stock | 17K | $21.4K | $1.26 | Jun 1, 2024 | Direct |
| Aclaris Therapeutics, Inc. | Director | Restricted Stock Units | 4.79K | $4.94K | $1.03 | Jun 6, 2024 | Direct |
| Passage BIO, Inc. | Director | Director Stock Option (right to buy) | 47.7K | May 21, 2024 | Direct | ||
| Aclaris Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 15.8K | Jun 6, 2024 | Direct | ||
| Aceragen, Inc. | Director | Common Stock | 0 | $0.51 | Aug 10, 2023 | By Trust |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics, Inc. | Jun 6, 2024 | 2 | $0 | 4 | Jun 10, 2024 | Director |
| ACRS | Aclaris Therapeutics, Inc. | Jun 1, 2024 | 2 | $0 | 4 | Jun 4, 2024 | Director |
| PASG | Passage BIO, Inc. | May 21, 2024 | 1 | $0 | 4 | May 23, 2024 | Director |
| MRUS | Merus N.V. | May 7, 2024 | 1 | $0 | 4 | May 9, 2024 | Director |
| ACGN | Aceragen, Inc. | Aug 10, 2023 | 1 | -$26 | 4 | Aug 11, 2023 | Director |
| MRUS | Merus N.V. | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
| ACRS | Aclaris Therapeutics, Inc. | Jun 1, 2023 | 4 | $0 | 4 | Jun 5, 2023 | Director |
| PASG | Passage BIO, Inc. | May 25, 2023 | 1 | $0 | 4 | May 26, 2023 | Director |
| IDRA | IDERA PHARMACEUTICALS, INC. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
| ACRS | Aclaris Therapeutics, Inc. | Jun 2, 2022 | 4 | $0 | 4 | Jun 6, 2022 | Director |
| MRUS | Merus N.V. | May 31, 2022 | 1 | $0 | 4 | Jun 2, 2022 | Director |
| PASG | Passage BIO, Inc. | May 31, 2022 | 1 | $0 | 4 | Jun 1, 2022 | Director |
| PASG | Passage BIO, Inc. | May 26, 2022 | 1 | $0 | 4 | May 31, 2022 | Director |
| IDRA | IDERA PHARMACEUTICALS, INC. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |
| ACRS | Aclaris Therapeutics, Inc. | Jun 3, 2021 | 2 | $0 | 4 | Jun 4, 2021 | Director |
| MRUS | Merus N.V. | May 28, 2021 | 1 | $0 | 4/A | Jun 16, 2021 | Director |
| MRUS | Merus N.V. | May 28, 2021 | 0 | $0 | 3 | Jun 2, 2021 | Director |
| PASG | Passage BIO, Inc. | May 27, 2021 | 1 | $0 | 4 | Jun 1, 2021 | Director |